Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Lupski Lab, |
RCV000454177 | SCV000538001 | likely pathogenic | Abnormal brain morphology | criteria provided, single submitter | research | ||
Gene |
RCV001597135 | SCV001831855 | uncertain significance | not provided | 2020-08-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 31589614, 26539891) |
Labcorp Genetics |
RCV001865410 | SCV002183320 | uncertain significance | Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with serine at codon 645 of the MTO1 protein (p.Arg645Ser). The arginine residue is highly conserved and there is a moderate physicochemical difference between arginine and serine. This variant is present in population databases (rs746382157, ExAC 0.02%). This missense change has been observed in individual(s) with congenital brain abnormalities (PMID: 26539891). This variant is also known as c.C2053A (p.R685S). ClinVar contains an entry for this variant (Variation ID: 402215). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |